Refametinib (R enantiomer)
Based on 1 publication(s) in Google Scholar
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 923032-38-6
- 화학식: C19H20F3IN2O5S
- 분자량:572.34
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Refametinib (R enantiomer)
MoreAll MEK Isoforms
More
Biological Activity
제품 설명
IC50 & Target
[1]|
MEK 2-15 nM (EC50) |
In Vitro
Refametinib R enantiomer is the R enantiomer of Refametinib . Refametinib R enantiomer is an inhibitor of MEK and is useful in treatment of cancer and other hyperproliferative diseases[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 923032-38-6
-
분자량 572.34
-
화학식 C19H20F3IN2O5S
-
SMILES
O=S(C1(C[C@H](CO)O)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
-
Synonyms
BAY 869766 R enantiomer; RDEA119 R enantiomer
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Sci Adv
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS. [Abstract]2019 Aug 14;5(8):eaav8463. PMID: 31453322
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)